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KIDNEY TRANSPLANTATION IN THE ABSENCE OF THE 
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The iliac fossa is the standard site for a kidney allograft. In 
rare cases, the iliac veins or the inferior vena cava may be 
occluded or congenitally absent—thus, an alternative site 
and type of venous drainage are required. We report herein a 
case of intraabdominal kidney transplantation in a young 
patient whose infrarenal vena cava was absent. We also 
review the pertinent literature on this subject.
The recipient was an 18-year-old man with end-stage renal 
failure due to congenital bilateral kidney hypoplasia. He 
began hemodialysis at age 7. At age 9, he received a cadaver 
kidney graft that was placed in the right iliac fossa. The iliac 
vein and inferior vena cava were noted to be absent; they had 
been replaced by a conglomerate of tortuous vessels, to which 
the transplant renal vein was attached. Although immediate 
graft function was satisfactory, it was gradually lost due to 
repeated rejection episodes. At age 12, he received a second 
kidney graft (donated by his father) that was placed in the 
left iliac fossa. Again, a venous conglomerate was found but 
no iliac vein. One of these vessels was used as the recipient 
site for venous connection. Graft thrombosis occurred and the 
graft was removed on postoperative day 1. The patient re­
turned to peritoneal dialysis and later to hemodialysis. He 
also suffered from repeated episodes of deep venous throm­
bosis of the lower extremities, Coagulation study results, 
including levels of protein C, protein S, and antithrombin III, 
were normal.
At age 19, he was referred to the University of Minnesota 
for evaluation for a third kidney transplant. A venogram 
showed absence of the inferior vena cava below the level of 
the right gonadal vein; a large lumbar vein was present on 
the left side. This vein presumably was responsible for ve­
nous drainage of the lower abdomen and lower extremities 
through a collateral paravertebral venous network. In both 
iliac fossae, a network of tortuous vessels was present, but no 
iliac vein (Fig. 1). The patient’s brother, a 23-year-old HLA- 
identical match, was medically eligible for living-related do­
nation. An angiogram showed that his right kidney was
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supplied by three arteries; his left kidney, supplied by two 
arteries, was selected for procurement.
On June 23, 1994, an intraabdominal kidney transplant 
was done through a midline incision (Fig. 2). The recipient’s 
right kidney was absent and his left kidney was atrophic. The 
inferior vena cava was atretic below the level of the right 
gonadal vein. Both the right and the left renal veins were of 
small caliber. A large lumbar vein was present on the left 
side. During dissection, patency of these collateral veins was 
preserved, to conserve blood flow and minimize the risk of 
postoperative thrombosis. The donor operation was routine, 
except that the entire length of ureter was mobilized. After 
recipient dissection, vascular clamps were placed on the in- 
frahepatic vena cava and on the aorta. A venotomy was done 
on the infrahepatic vena cava, and an excellent backflow was 
noted. This venotomy served as the recipient site for the 
end-to-side venous anastomosis. The two renal arteries were 
separately anastomosed end-to-side to the recipient aorta. 
The ureter was drawn through a retroperitoneal tunnel mim­
icking the normal anatomy, and an intravesical ureteroneo- 
cystostomy was done using the Leadbetter-Politano tech­
nique. Immunosuppression consisted of cyclopsorine, 
prednisone, azathioprine, and an induction course of anti­
lymphocyte therapy (ATGAM, Upjohn). Graft function was 
excellent immediately. Low-do se heparin (200 units/h) was 
administered, then low-dose coumadin (3 mg/day). Now, at 2 
months posttransplant, the serum creatinine level is 1 mg/dl.
Hetero topic placement of kidney allografts in the iliac fossa 
is the norm. In some circumstances, however, abnormalities 
of the venous system may preclude use of this site. Such 
abnormalities include absence of suitable iliac veins or of the 
intraabdominal vena cava. They can be congenital, or secondary 
to thrombosis related to hypercoagulability, previous placement 
of a vena cava filter, trauma, or perinatal catheterization of the 
umbilical vein (1-5). Total absence of the vena cava is a rare 
congenital anomaly, often associated with cardiac or other vis­
ceral malformations (e.g., malrotation, dextrocardia, malforma­
tion of the spleen) (5). The precise cause of the absent iliac vein 
and infrarenal vena cava in our patient remains unclear.
Whatever the cause of the venous anomaly, a uniform 
consequence is inappropriate venous drainage from the lower 
extremities. This was reflected in our patient by repeated
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F ig u re  1 . Patients venogram showing (A) a network of tortuous 
vessels in the left iliac fossa, but no iliac vein, (B) absence of the 
inferior vena cava below the level of the right gonadal vein, and (C) 
venous drainage of the lower abdomen and lower extremities 
through a collateral paravertebral venous network.
episodes of deep venous thrombosis, and even more dramat­
ically by the rapid graft thrombosis after his second trans­
plant. An important lesson from this case is to use caution 
when placing a kidney graft in the iliac fossa in the absence 
of normal venous anatomy. Venous congestion and graft 
thrombosis may occur. In an experimental study, all minipigs 
who underwent a kidney autotransplant after resection of
the vena cava developed graft thrombosis, despite develop­
ment of a collateral circulation before cavai resection (4). 
Therefore, patients with end-stage renal disease who have no 
suitable iliac vein or vena cava require an alternative graft 
site (intraabdominal or native lumbar fossa) and type of 
venous drainage (cavai or portal).
If only the infrarenal vena cava is absent, the vena cava 
immediately below the liver can be used for graft venous 
implantation, as in this case. Patency of the infrahepatic 
vena cava can be assessed preoperatively by venogram and 
confirmed intraoperatively by an adequate backflow after 
venotomy. All venous tributaries from this segment of upper 
vena cava (remnant renal veins, gonadal veins, lumbar veins) 
must be left intact, both to maximize the blood flow in this 
residual portion of the vena cava and to preserve collateral 
circulation and venous drainage from the lower abdomen and 
lower extremities. Finally, the venotomy should be made as 
large as possible to ensure a widely patent anastomosis and 
adequate venous emptying from the allograft. Alternatively, 
one of the native renal veins may serve as the recipient site 
for an end-to-side anastomosis with the transplant renal 
vein. We employed this technique in another kidney recipient
F igure 2, Illustration of the intraabdominal transplant in the ab­
sence of the infrarenal vena cava. Renal vein was attached end-to- 
side to the infrahepatic vena cava. Renal arteries were attached 
end-to-side to the aorta. An intravesical ureteroneocystostomy was
performed.
June 27, 1995 BRIEF COMMUNICATIONS 1741
with thrombosis of the infrarenal vena cava secondary to the 
use of a vena cava filter (I). At our institution, we have used 
an enlarged patent ovarian vein for venous implantation of a 
pancreas allograft in a patient with no suitable vena cava 
(Sutherland DER, unpublished observations).
If  the vena cava is totally absent due to extensive throm­
bosis or agenesis, the only option is to use the portal system 
for graft implantation. The feasibility of draining various 
organ allografts (kidneys, heart, pancreas, small bowel) into 
the portal system has been demonstrated experimentally 
(5—8), Clinically, the splenic vein has been successfully used 
to drain pancreas allografts (9-11), We have used recipient 
inferior mesenteric vessels to revascularize segmental pan­
creas allografts; the graft splenic artery and vein were anas­
tomosed end-to-end to the inferior mesenteric vessels, and no 
thrombosis occurred (12).
We know of only two reports of intraabdominal kidney 
transplants using the portal system for venous revascular­
ization. One recipient was a child who had previously under­
gone nephrectomy and vena cava resection for Wilms* tumor; 
the renal artery was anastomosed end-to-side to the recipient 
aorta and the renal vein end-to-side to the splenic vein. 
Urinary continuity was restored by ureteroureterostomy, Ra­
dioisotopic scan 1 year posttransplant showed good perfusion 
and no signs of urinary stasis (IS). In another recipient, the 
inferior mesenteric vein was used for revascularization; similar 
to our case, the ureter was reimplanted into the bladder using 
the standard nonrefluxing Leadbetter-Politano technique (14),
There is a theoretical immunologic advantage in using the 
portal system for venous connection. Several reports indicate 
th a t rejection can be ameliorated by portal drainage, an 
effect possibly due to inactivation by the liver of circulating 
transplant antigens (8). Experimentally, in certain strain of 
ra ts, port ally drained kidney, heart, and small bowel al­
lografts survive longer (5-8). The clinical reality of this effect 
remains controversial since it has not been repeatedly ob­
served in larger animals (15). Based on the few human cases 
of por tally drained kidney and pancreas allografts, there is 
no evidence that portal implantation dramatically amelio­
ra tes rejection, Using the portal system for graft vascular 
connection may even convey a physiologic disadvantage: por­
ta l  pressure is higher than cavai pressure, a hemodynamic 
difference that could impair the venous drainage of port ally 
versus systemically drained allografts.
One alternative to intra ab dominai placement is the ortho - 
topic position. Gil-Vernet described a graft placement in the 
native kidney fossa through an extraperitoneal lumbar ap­
proach, similar to that used for nephrectomy from a living 
donor. The transplant renal artery was attached end-to-end 
to the splenic artery or end-to-side to the aorta, and the 
transplant renal vein was attached end-to-end to the native 
renal vein. Pyelopyelostomy was used for urinary reconstruc­
tion (10, 11). Similarly, Talbot-Wright described a splenore­
na l anastomosis in two patients with total agenesis of the 
inferior vena cava. The kidney was placed orthotopically, 
with end-to-end anastomosis of the transplant renal vein to 
the native splenic vein and of the transplant renal artery to 
the  native splenic artery. In unexperienced hands, the ortho­
topic method conveys a significant risk of pancreatic injury 
(16), We believe this delicate technique should be used only 
in  patients with abnormal venous anatomy in whom intra­
abdominal placement is not feasible.
When the vascular anastomoses are in the upper abdomen, 
reconstructing the urinary tract is more difficult. Of concern 
is the excessive distance between the graft and the bladder 
and the resulting risk of ischemia and stenosis of the distal 
ureter. However, an auto transplanted ureter, by definition 
completely deprived of its original blood supply, does survive 
with normal peristalsis and appearance and with preserved 
histology. Neovascularization can develop due to either 
repermeabilization of original vessels or to formation of new 
ones (17). Neovascularization of recipient origin can be im­
proved by keeping periureteral tissues intact during procure­
ment and by drawing the ureter through a retroperitoneal 
tunnel, as in our case. Development of new vessels can also 
be improved by wrapping the ureter with a pedicle of great 
omentum (18). Finally, a factor limiting the feasibility of a 
direct uretereroneocystostomy may be an insufficient length 
of available donor ureter. In such a case, a pyelopyelostomy or 
ureteroureterostomy can be done if the recipient urinary tract is 
anatomically intact and the vesicoureteral reflux is absent.
In summary, our technique allowed us to safely do a living - 
related kidney transplant after a standard heterotopic trans­
plant had failed due to the absence of the infrarenal vena 
cava. The recipient would otherwise have been condemned to 
lifetime dialysis.
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ACETAZOLAMIDE-ASSOCIATED NEPHROCALCINOSIS IN A 
TRANSPLANT KIDNEY
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Acetazolamide is a carbonic anhydrase inhibitor used in 
the treatment of glaucoma. Known renal side effects in pa­
tients treated with acetazolamide include sulfonamide-type 
nephropathy (1), calculus formation (2), and ureteric colic (3).
Recently we reported the first case of nephro calcino sis in 
native kidneys secondary to diamox therapy (4), We now 
present the imaging findings of nephrocalcinosis in a trans­
plant kidney associated with acetazolamide therapy.
A 22-year-old man developed renal failure from chronic 
glomerulorephritis and underwent kidney transplantation 
from a living donor, who was his sister. At age 24, he devel­
oped glaucoma that was treated with acetazolamide 250 mg 
every 6 hr. The glaucoma was presumed secondary to his 
chronic immunosuppressive therapy with prednisone 15 mg 
and azathioprine 100 mg/day.
At age 31, the patient's serum creatinine had risen to 
155-172 mol/L. The patient was asymptomatic. Physical ex­
amination revealed chronic ocular findings of glaucoma.
Blood pressure averaged 127/88 on hydrazaline 100 mg and 
propanalol 80 mg/day. The remainder of the examination was 
unremarkable. Serum hemoglobin was 17.6 g/L. Serum chlo­
ride measured 111-114, serum bicarbonate 20—21, sodium 
145, and potassium 4.1 mmol/L. Serum calcium was 2.5 
mmol/L; parathyroid hormone, phosphate, and uric acid were 
normal. Urinalysis showed 10-15 red blood cells and 5-10 
white blood cells per high power field and trace proteinuria.
The 24-hr urine excretion of calcium at 3.0 and oxalate at 250 
jumol were normal. Urine pH was 6 to 7; cultures including 
those for tuberculosis were negative. The serum and urine 
chemistry were compatible with mild renal tubular acidosis 
secondary to acetazolamide therapy.
A sonogram of the transplant kidney (Fig. 1) demonstrated 
multiple foci of markedly increased echogenicity with poste­
rior acoustic attenuation involving the distribution of the 
medulla. A plain radiograph of the kidney (Fig. 2) confirmed
F igure 1. Sonogram of transplant kidney demonstrates multiple 
foci of increased echogenicity within the medulla (M) with associated 
posterior acousting shadowing (arrows).
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multiple small discrete parenchymal calcifications compati­
ble with medullary nephrocalcinosis.
The mild renal tubular acidosis secondary to acetazol­
amide therapy was considered to be responsible for the pa­
tient’s medullary nephrocalcinosis and deterioration in renal 
function. The acetazolamide was discontinued and the pa­
tient’s creatinine fell to 136 pmoVL in one year and later to 
95-105 jumol/L. Serum bicarbonate rose to 27 and chloride 
fell to 107 mmol/L. Urine pH fell to the 5-6 range, and red 
blood cells and white blood cells to 2-4 per high power field 
on urinalysis. At age 44, the patient has done well without 
passing any calculi or having any episodes of renal colic. The 
creatinine has remained stable, and follow-up radiographs 
and sonograms have demonstrated no change from the pa­
tient’s initial nephrocalcinosis at age 31. He has not been 
treated for transplant rejection since age 22. The glaucoma 
became stable on 10 mg daily oral prednisone and timolol 
0,5% and isoptocarpine 2% eye drops.
Nephrocalcinosis, calcifications located within the renal 
parenchyma, is classified as cortical or medullary. Cortical
